JP2019099579A5 - - Google Patents

Download PDF

Info

Publication number
JP2019099579A5
JP2019099579A5 JP2018228252A JP2018228252A JP2019099579A5 JP 2019099579 A5 JP2019099579 A5 JP 2019099579A5 JP 2018228252 A JP2018228252 A JP 2018228252A JP 2018228252 A JP2018228252 A JP 2018228252A JP 2019099579 A5 JP2019099579 A5 JP 2019099579A5
Authority
JP
Japan
Prior art keywords
composition
bone
bone loss
disease associated
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018228252A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019099579A (ja
JP7029172B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019099579A publication Critical patent/JP2019099579A/ja
Publication of JP2019099579A5 publication Critical patent/JP2019099579A5/ja
Application granted granted Critical
Publication of JP7029172B2 publication Critical patent/JP7029172B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018228252A 2017-12-07 2018-12-05 骨量減少と関連する疾病を治療又は予防し、骨格構造及び生体力学的骨強度を改善する組成物 Active JP7029172B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762595697P 2017-12-07 2017-12-07
US62/595,697 2017-12-07

Publications (3)

Publication Number Publication Date
JP2019099579A JP2019099579A (ja) 2019-06-24
JP2019099579A5 true JP2019099579A5 (enExample) 2021-08-12
JP7029172B2 JP7029172B2 (ja) 2022-03-03

Family

ID=64559585

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018228252A Active JP7029172B2 (ja) 2017-12-07 2018-12-05 骨量減少と関連する疾病を治療又は予防し、骨格構造及び生体力学的骨強度を改善する組成物

Country Status (6)

Country Link
US (1) US10881634B2 (enExample)
EP (1) EP3494973B1 (enExample)
JP (1) JP7029172B2 (enExample)
KR (1) KR102376603B1 (enExample)
CN (1) CN109939118A (enExample)
TW (1) TWI756495B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025117337A1 (en) * 2023-11-28 2025-06-05 GreenStone Biosciences, Inc. Genistein phosphate derivatives
CN118359663B (zh) * 2024-04-26 2024-12-13 西安交通大学医学院第一附属医院 线粒体靶向染料木素衍生物及其在制备抗心肌缺血再灌注损伤药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999063995A1 (en) * 1998-06-12 1999-12-16 Vyrex Corporation Isoflavone derivatives
US6541613B2 (en) * 2000-12-15 2003-04-01 Uyrex Corporation Isoflavone derivatives
WO2005049627A1 (en) * 2003-11-18 2005-06-02 Novogen Research Pty Ltd Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
KR20100051829A (ko) * 2007-07-31 2010-05-18 리머릭 바이오파르마 인코오포레이티드 인산화된 피론 유사체 및 방법
TR201004464A2 (tr) * 2010-06-03 2012-11-21 B�Lg�� Mahmut Kemik erimesi için formülasyon.
US8900635B2 (en) * 2010-11-15 2014-12-02 Humanetics Corporation Nanoparticle isoflavone compositions and methods of making and using the same
CN102351828A (zh) * 2011-08-16 2012-02-15 李荣立 一种提取金雀异黄素的新工艺
CN102488210B (zh) * 2011-12-27 2013-06-19 西南大学 染料木素水凝胶的复合物及其制备方法
CN105381470B (zh) * 2015-11-27 2018-11-02 广东医科大学 一种改性染料木素及其应用
TWI670374B (zh) * 2016-04-25 2019-09-01 國立臺灣大學 具有苯並吡喃酮類磷酸酯合成酶活性之多肽、包含編碼該多肽之核酸序列之微生物及苯並吡喃酮類磷酸酯衍生物之製備方法

Similar Documents

Publication Publication Date Title
JP2017057230A5 (enExample)
FI3710000T3 (fi) Tradipitantti käytettäväksi gastropareesin hoidossa
HRP20220902T3 (hr) Pripravci i njihova upotreba u liječenju multiple skleroze
JP2015512406A5 (enExample)
JPWO2021099783A5 (enExample)
JP2019502741A5 (enExample)
JPS59193821A (ja) 抗不安薬としてのフルオキセチンの使用法
RU2007103306A (ru) Композиции на основе ризедроната и способы их применения
JP2019099579A5 (enExample)
JPWO2021099781A5 (enExample)
JPWO2021099777A5 (enExample)
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
JPWO2021099775A5 (enExample)
KR100551652B1 (ko) 라미부딘 및 지도부딘을 함유하는 제약 조성물
RU2007132971A (ru) Способы и материалы с транс-кломифеном для лечения мужского бесплодия
RU2006139819A (ru) Применение симетикона для предрасположенных к запорам пациентов
CN108743601A (zh) 一种抗溃疡性结肠炎的黄芩苷-黄芩素组合物及其制剂
JP2021066751A (ja) 経口用医薬組成物
CN106924270B (zh) 一种含有奥利司他的具有减肥功能的药物组合物
KR101978459B1 (ko) 조루증 치료용 약학 조성물 및 조루증 치료 방법
BG63103B1 (bg) Използуване на алендронат за профилактика на остеопороза
JP6940265B2 (ja) 止瀉剤組成物
CA2469702A1 (en) Darifenacin for use in the treatment of urgency induced by overactive bladder
RU2013124994A (ru) КОМБИНАЦИЯ БЕВАЦИЗУМАБА И 2,2-ДИМЕТИЛ-N-((S)-6-ОКСО-6,7-ДИГИДРО-5Н-ДИБЕНЗО[b,d]АЗЕПИН-7-ИЛ)-N'-(2,2,3,3,3-ПЕНТАФТОР-ПРОПИЛ)-МАЛОНАМИДА ДЛЯ ЛЕЧЕНИЯ ПРОЛИФЕРАТИВНЫХ ЗАБОЛЕВАНИЙ
IL190511A (en) Delayed formulation for Pralencazen